Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept versus placebo for short-term changes in wrist synovitis in methotrexate-inadequate response rheumatoid arthritis
2006-003768-67Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Abatacept + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: Change in wrist synovitis by gadolinium-enhanced MRI (OMERACT 6 RA MRI score). Started Feb 2007; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-003768-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003768-67.